Skip to main content
editorial
. 2012 Oct 1;186(7):575–578. doi: 10.1164/rccm.201208-1437ED

TABLE 3.

FISCAL YEAR 2010 EXTRAMURAL NHLBI PROJECTS (INCLUDING ALL MECHANISMS) BY RCDC TOPICS THAT RELATE TO SPECIFIC DISEASE CATEGORIES

Nonclinical Projects
Clinical Projects
RCDC Topic No. Total Funding (% Extramural Funding) Median Cost per Project (25th, 75th Percentiles) No. Total Funding (% Extramural Funding) Median Cost per Project (25th and 75th Percentiles)
Cardiovascular 1,913 865,499 (35%) 374 (270, 414) 1,005 539,545 (22%) 379 (142, 658)
Atherosclerosis 393 243,991 (10%) 375 (303, 414) 271 160,713 (7%) 401 (198, 722)
CAD 440 221,791 (9%) 380 (323, 420) 267 156,696 (6%) 422 (200, 721)
Heart disease 1,258 595,073 (24%) 375 (286,417) 727 410,409 (17%) 386 (147, 685)
Hypertension 231 105,746 (4%) 370 (312, 401) 111 50,652 (2%) 371 (151, 594)
Lung 697 325,329 (13%) 376 (293, 410) 605 283,649 (12%) 375 (137, 610)
COPD 55 58,142 (2%) 410 (346, 1,730) 84 44,767 (2%) 372 (142, 703)
Asthma 94 40,732 (2%) 373 (249, 400) 144 79,092 (3%) 407 (160, 750)
ARDS 110 61,255 (3%) 384 (335, 410) 82 29,665 (1%) 326 (135, 415)
Cystic fibrosis 42 21,253 (1%) 371 (326, 475) 37 17,928 (1%) 385 (173, 648)
Sleep 55 16,969 (1%) 367 (230, 393) 97 51,527 (2%) 405 (189, 607)
Hematology 406 165,228 (7%) 370 (191, 410) 295 139,989 (6%) 375 (140, 464)
Sickle cell 21 9,325 (<1%) 338 (139, 458) 60 28,774 (1%) 303 (125, 451)
Cooley anemia 9 4,949 (<1%) 394 (373, 429) 9 8,112 (<1%) 411 (390, 1,327)

Definition of abbreviations: ARDS = acute respiratory distress syndrome; CAD = coronary artery disease; COPD = chronic obstructive pulmonary disease.

All costs are in units of $1,000. All data were obtained from the NIH Research Portfolio Online Reporting Tools (RePORT). Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) are found at http://report.nih.gov/categorical_spending.aspx. RCDC topics are not necessarily exclusive of one another (hence total percentages exceed 100). Clinical projects are those categorized in RCDC as “Clinical Research” or “Clinical Trials Total NHLBI extramural funding in fiscal year 2010 was $2,441,772,050. Numbers of projects, total funding in each RCDC area, and median (25th, 75th percentiles) costs per project were calculated using the SAS 9.2 “Proc Tabulate” procedure.